drugset / Trial / NCT06305182

Metreleptin in Anorexia Nervosa

NCT06305182

Phase 2 Recruiting 50 enrolled Gabriella Milos
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The treatment of anorexia nervosa often proves to be difficult. There are no drugs that work specifically for the treatment of anorexia nervosa. Experimental administration of metreleptin (synthetically produced leptin) to patients with anorexia nervosa has produced positive results. This study tests the effect of metreleptin in comparison with placebo, which could potentially make treatment easier. The aim of the study is to investigate whether treatment with metreleptin can help to reduce the symptoms of anorexia nervosa and improve mood and weight.

Timeline

Start
2024-05-31
Primary completion
2026-08-30
Completion
2026-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metreleptin Protein / enzyme biologic 1.2 ml Subcutaneous
Subject Metreleptin Protein / enzyme biologic 1.8 ml Subcutaneous

Indications